Product Description

POSITAZ 4.5 GM Injection is a combination injectable antibiotic containing Piperacillin 4 g and Tazobactam 500 mg per vial. Piperacillin is a penicillin-class antibacterial agent, while tazobactam is a beta-lactamase inhibitor that helps extend the antibacterial activity of piperacillin against susceptible beta-lactamase-producing bacteria.

The product is supplied as a single-dose vial and is labelled for intravenous use only. It belongs to the Antibiotics therapeutic category and is intended for use under the supervision of a qualified healthcare professional.

Uses / Therapeutic Information

Piperacillin and tazobactam injection is used by healthcare professionals for the treatment of susceptible bacterial infections.

Depending on the clinical indication and bacterial susceptibility, piperacillin/tazobactam may be used in hospital settings for infections such as:

• Respiratory tract infections
• Intra-abdominal infections
• Urinary tract infections
• Skin and soft-tissue infections
• Other serious bacterial infections

Important: Specific indications, dosage, dilution, frequency and duration should follow the approved product information and be determined by a qualified healthcare professional.

Availability & Franchise Enquiries

Contact the Positive Medicare team for the latest pack presentation, minimum order quantity, territory availability and commercial terms.

Pharmaceutical distributors, stockists, hospitals and prospective PCD pharma franchise partners can enquire about product availability and related pharmaceutical business opportunities.

Important: This page is intended for healthcare professionals and pharmaceutical business enquiries. It does not provide individual treatment, dosage, dilution or administration advice. Injectable antibiotics should be used and administered only under the direction of qualified healthcare professionals and according to approved product labelling.